# The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Study · id `cardio:ct-nct06321575` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06321575](<https://clinicaltrials.gov/study/NCT06321575>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06321575

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 159 participants.

## Technical summary

Registry record NCT06321575. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-20 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 159 participants (planned count; ClinicalTrials.gov record NCT06321575, source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)
- Started: 2024-06-20 (actual) (ClinicalTrials.gov record NCT06321575, source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT06321575, source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)
- Completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT06321575, source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06321575, source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06321575-2026-08-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Acronym: GREAT
- Condition: Peripheral Arterial Disease
- Intervention (Device): Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)
- Lead sponsor: Nipro Vascular Innovations Americas, Inc
- Lead sponsor class: INDUSTRY
- Collaborator: Bright Research, Inc.
- Collaborator class: UNKNOWN
- Collaborator: Yale Cardiovascular Research Group
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Yale Cardiovascular Research Group (`cardio:org-yale-cardiovascular-research-group`)

## Provenance

Content hash: 7e7c081b432e2d44bc8d3c095b749c9c3f1b3eb1df7d44d3f2ff7b42fbe23b89
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
